Med library header>

 WHO Essential Medicines Library - EMLib   

  WHO Essential Medicines web siteWHO web

Nematodes - trichuriasis

Introduction, etiology

.html
Infection is transmitted by eggs or larvae, which begin their cycle of development within the human host when, depending on the species, they either actively penetrate intact skin or are ingested or, very rarely, inhaled. The larvae of the most widely prevalent species remain dormant but potentially infective for long periods in contaminated soil; the larvae or cysts of other species are ingested when the flesh of reservoir hosts is eaten either raw or undercooked.

Trichuriasis, or whipworm infection, which is caused by the nematode worm Trichuris trichiura, is estimated to affect some 1050 million people and of these, an estimated 10 000 die annually (2002). Children aged 5 to 14 years are particularly vulnerable. Most cases occur in the moist, warm, tropical regions of Asia, Africa, Central and South America, and the Caribbean islands.

Recommended treatments

.html



mebendazole
.html
chewable tablet, 100 mg, 500 mg

  .html

Adults and children over 2 years:
For mild to moderate infections: A single dose of 500 mg
Heavier infections: 500 mg for 3 consecutive days
or
albendazole
.html
chewable tablet, 400 mg

  .html

Adults and children over 2 years:
For mild to moderate infections: A single dose of 400 mg
Heavier infections: 400 mg for 3 consecutive days

References
1. .html
WHO Model Prescribing Information. Drugs used in parasitic diseases second edition, 1995. 146 pages [E, F, S] ISBN 92 4 140104 4 Sw.fr. 35.-/US $31.50. In developing countries Sw.fr.24.50.
  Sales Information: http://www.who.int/bookorders/index.htm

2. .html
Intestinal nematodes, WHO link page
   http://www.who.int/health-topics/intestinal.htm

3. .html
Parasites and Health, Trichuriasis, Centers for Disease Control and Prevention, USA
   http://www.dpd.cdc.gov/dpdx/HTML/Trichuriasis.htm

4. .html
Report of the WHO Informal Consultation on the use of praziquantel during pregnancy/lactation and albendazole/mebendazole in children under 24 months, Geneva, 8-9 April, 2002, WHO/CDS/CPE/PVC/2002.4
   http://www.who.int/wormcontrol/documents/en/pvc_20024full.pdf

5. .html
Benzimidazoles: use in children, Essential Medicines, WHO Drug Information, Vol 17, No. 1, 2003
   http://www.who.int/druginformation/vol17num1_2003/vol17-1.pdf


Model Formulary search